Mercaptopurine Suspension
Product Images NDC 0054-0879

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 0054-0879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (100 mL per bottle)

Label for Mercaptopurine Oral Suspension, 2000 mg/100 mL (20 mg/mL) in a 100 mL bottle. The label includes dosage strength, instructions to shake well before use, inactive ingredients, and storage directions. Distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Bottle Carton (100 mL per bottle)

Mercaptopurine Oral Suspension 20 mg/mL (2000 mg/100 mL) carton label showing the product name and strength prominently on front and side panels. The label includes instructions to shake vigorously for at least 30 seconds before use, storage conditions, and safety warnings to keep out of reach of children. Ingredients and packaging contents are listed, including a 100 mL glass bottle and dispensing syringes. The labeler is Hikma Pharmaceuticals USA Inc. with their logo in red on the side.*

FDA Label Image

Chemical Structure (Mercaptopurine 01)

Chemical structure of mercaptopurine hydrate, showing a purine base with sulfur and nitrogen atoms, and a water molecule (H2O) indicated as a hydrate form.*

FDA Label Image

Figure A (Mercaptopurine 02)

An instructional illustration showing a hand holding a bottle and shaking it with back-and-forth motion indicated by curved arrows. This likely indicates the need to shake the suspension medication before use.*

FDA Label Image

Figure B (Mercaptopurine 03)

An instructional illustration showing how to open a child-resistant cap on a medicine bottle by pressing down and simultaneously turning the cap counterclockwise. The image depicts a close-up of two hands demonstrating the technique on the bottle.*

FDA Label Image

Figure C (Mercaptopurine 04)

An instructional illustration showing hands opening a bottle of liquid medication by twisting or pulling the cap upwards, indicated by a downward arrow. The bottle has a detached cap placed beside it, suggesting how to access the oral suspension inside.*

FDA Label Image

Figure D (Mercaptopurine 05)

An illustration diagram of an oral syringe labeled to show the components: Tip, Markings, Barrel, and Plunger. The diagram highlights the parts of the syringe used to measure and administer liquid medication.*

FDA Label Image

Figure E (Mercaptopurine 06)

An instructional illustration showing a hand holding a bottle and another hand inserting a syringe into the bottle's opening, indicated by a downward arrow. The image likely demonstrates how to withdraw MERCAPTOPURINE oral suspension from the bottle using a syringe.*

FDA Label Image

Figure F (Mercaptopurine 07)

An instructional illustration showing a hand holding a vial or bottle inverted above a syringe, with another hand drawing liquid into the syringe. A downward arrow indicates the drawing motion from the vial into the syringe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.